-
1
-
-
84875629527
-
The molecular basis of leukocyte recruitment and its deficiencies
-
Schmidt S, Moser M, Sperandio M. The molecular basis of leukocyte recruitment and its deficiencies. Mol Immunol 2012;55: 49-58
-
(2012)
Mol Immunol
, vol.55
, pp. 49-58
-
-
Schmidt, S.1
Moser, M.2
Sperandio, M.3
-
2
-
-
0038262824
-
Systemic disease and periodontitis: Manifestations of neutrophil dysfunction
-
Deas D.E., Mackey SA, McDonnell HT. Systemic disease and periodontitis: manifestations of neutrophil dysfunction. Periodontol 2000;32:82-104
-
(2000)
Periodontol
, vol.32
, pp. 82-104
-
-
Deas, D.E.1
Mackey, S.A.2
McDonnell, H.T.3
-
3
-
-
0023083976
-
Leukocyte adhesion deficiency: An inherited defect in the Mac-1, LFA-1, and p150,95 glycoproteins
-
Anderson DC, Springer TA. Leukocyte adhesion deficiency: an inherited defect in the Mac-1, LFA-1, and p150,95 glycoproteins. Annu Rev Med 1987;38: 175-94
-
(1987)
Annu Rev Med
, vol.38
, pp. 175-194
-
-
Anderson, D.C.1
Springer, T.A.2
-
4
-
-
84894443827
-
Neutrophil homeostasis and periodontal health in children and adults
-
Hajishengallis E, Hajishengallis G. Neutrophil homeostasis and periodontal health in children and adults. J Dent Res 2014;93:231-7
-
(2014)
J Dent Res
, vol.93
, pp. 231-237
-
-
Hajishengallis, E.1
Hajishengallis, G.2
-
5
-
-
84899092312
-
Defective neutrophil recruitment in leukocyte adhesion deficiency type i disease causes local IL-17-driven inflammatory bone loss
-
Moutsopoulos NM, Konkel J, Sarmadi M, et al. Defective neutrophil recruitment in leukocyte adhesion deficiency type I disease causes local IL-17-driven inflammatory bone loss. Sci Transl Med 2014;6:229ra40
-
(2014)
Sci Transl Med
, vol.6
-
-
Moutsopoulos, N.M.1
Konkel, J.2
Sarmadi, M.3
-
6
-
-
15244344110
-
Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17
-
Stark M.A., Huo Y, Burcin TL, et al. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity 2005;22:285-94
-
(2005)
Immunity
, vol.22
, pp. 285-294
-
-
Stark, M.A.1
Huo, Y.2
Burcin, T.L.3
-
7
-
-
84891372427
-
Immunomicrobial pathogenesis of periodontitis: Keystones, pathobionts, and host response
-
Hajishengallis G. Immunomicrobial pathogenesis of periodontitis: keystones, pathobionts, and host response. Trends Immunol 2014;35:3-11
-
(2014)
Trends Immunol
, Issue.35
, pp. 3-11
-
-
Hajishengallis, G.1
-
8
-
-
0037292394
-
Are dental diseases examples of ecological catastrophes?
-
Marsh PD. Are dental diseases examples of ecological catastrophes? Microbiology 2003;149:279-94
-
(2003)
Microbiology
, vol.149
, pp. 279-294
-
-
Marsh, P.D.1
-
9
-
-
42949179437
-
Periodontal manifestation of leukocyte adhesion deficiency type i
-
Dababneh R, Al-Wahadneh AM, Hamadneh S, et al. Periodontal manifestation of leukocyte adhesion deficiency type I. J Periodontol 2008;79: 764-8
-
(2008)
J Periodontol
, vol.79
, pp. 764-768
-
-
Dababneh, R.1
Al-Wahadneh, A.M.2
Hamadneh, S.3
-
11
-
-
84892150941
-
Rac-null leukocytes are associated with increased inflammation-mediated alveolar bone loss
-
Sima C, Gastfreund S, Sun C, et al. Rac-null leukocytes are associated with increased inflammation-mediated alveolar bone loss. Am J Pathol 2014;184: 472-82
-
(2014)
Am J Pathol
, vol.184
, pp. 472-482
-
-
Sima, C.1
Gastfreund, S.2
Sun, C.3
-
12
-
-
84880330316
-
Commensal bacteria-dependent select expression of CXCL2 contributes to periodontal tissue homeostasis
-
Zenobia C, Luo XL, Hashim A, et al.commensal bacteria-dependent select expression of CXCL2 contributes to periodontal tissue homeostasis. Cell Microbiol 2013;15:1419-26
-
(2013)
Cell Microbiol
, vol.15
, pp. 1419-1426
-
-
Zenobia, C.1
Luo, X.L.2
Hashim, A.3
-
13
-
-
84855444617
-
A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1
-
Pillay J, Kamp VM, van Hoffen E, et al. A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1. J Clin Invest 2012;122: 327-36
-
(2012)
J Clin Invest
, vol.122
, pp. 327-336
-
-
Pillay, J.1
Kamp, V.M.2
Van Hoffen, E.3
-
14
-
-
84863393385
-
The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated inflammatory bone loss
-
Eskan M.A., Jotwani R, Abe T, et al. The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated inflammatory bone loss. Nat Immunol 2012;13:465-73
-
(2012)
Nat Immunol
, vol.13
, pp. 465-473
-
-
Eskan, M.A.1
Jotwani, R.2
Abe, T.3
-
15
-
-
0034515822
-
Leukocyte adhesion deficiency II-from A to almost Z
-
Etzioni A, Tonetti M. Leukocyte adhesion deficiency II-from A to almost Z. Immunol Rev 2000;178:138-47
-
(2000)
Immunol Rev
, vol.178
, pp. 138-147
-
-
Etzioni, A.1
Tonetti, M.2
-
16
-
-
84869857368
-
Porphyromonas gingivalis promotes Th17 inducing pathways in chronic periodontitis
-
Moutsopoulos NM, Kling HM, Angelov N, et al. Porphyromonas gingivalis promotes Th17 inducing pathways in chronic periodontitis. J Autoimmun 2012;39: 294-303
-
(2012)
J Autoimmun
, vol.39
, pp. 294-303
-
-
Moutsopoulos, N.M.1
Kling, H.M.2
Angelov, N.3
-
17
-
-
68249143144
-
The involvement of IL-23 and the Th17 pathway in periodontitis
-
Ohyama H, Kato-Kogoe N, Kuhara A, et al. The involvement of IL-23 and the Th17 pathway in periodontitis. J Dent Res 2009;88:633-8
-
(2009)
J Dent Res
, vol.88
, pp. 633-638
-
-
Ohyama, H.1
Kato-Kogoe, N.2
Kuhara, A.3
-
18
-
-
52649128246
-
A new inflammatory cytokine on the block: Re-thinking periodontal disease and the Th1/Th2 paradigm in the context of Th17 cells and IL-17
-
Gaffen SL, Hajishengallis G. A new inflammatory cytokine on the block: re-thinking periodontal disease and the Th1/Th2 paradigm in the context of Th17 cells and IL-17. J Dent Res 2008;87: 817-28
-
(2008)
J Dent Res
, vol.87
, pp. 817-828
-
-
Gaffen, S.L.1
Hajishengallis, G.2
-
19
-
-
84862860846
-
IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis
-
Krueger JG, Fretzin S, Suarez-Farinas M, et al. IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis. J Allergy Clin Immunol 2012;130:145-54.e9
-
(2012)
J Allergy Clin Immunol
, vol.130
-
-
Krueger, J.G.1
Fretzin, S.2
Suarez-Farinas, M.3
-
20
-
-
77950535421
-
LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase i randomized, double-blind, placebo-controlled, proof-of-concept study
-
Genovese MC, Van den Bosch F, Roberson SA, et al. LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I randomized, double-blind, placebo-controlled, proof-of-concept study. Arthritis Rheum 2010;62:929-39
-
(2010)
Arthritis Rheum
, vol.62
, pp. 929-939
-
-
Genovese, M.C.1
Van Den Bosch, F.2
Roberson, S.A.3
|